Literature DB >> 24414255

Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.

Marissa R Martinez1, Adam Cuker, Angela M Mills, Amanda Crichlow, Richard T Lightfoot, Irina N Chernysh, Chandrasekaran Nagaswami, John W Weisel, Harry Ischiropoulos.   

Abstract

The factors that contribute to pulmonary embolism (PE), a potentially fatal complication of deep vein thrombosis (DVT), remain poorly understood. Whereas fibrin clot structure and functional properties have been implicated in the pathology of venous thromboembolism and the risk for cardiovascular complications, their significance in PE remains uncertain. Therefore, we systematically compared and quantified clot formation and lysis time, plasminogen levels, viscoelastic properties, activated factor XIII cross-linking, and fibrin clot structure in isolated DVT and PE subjects. Clots made from plasma of PE subjects showed faster clot lysis times with no differences in lag time, rate of clot formation, or maximum absorbance of turbidity compared with DVT. Differences in lysis times were not due to alterations in plasminogen levels. Compared with DVT, clots derived from PE subjects showed accelerated establishment of viscoelastic properties, documented by a decrease in lag time and an increase in the rate of viscoelastic property formation. The rate and extent of fibrin cross-linking by activated factor XIII were similar between clots from DVT and PE subjects. Electron microscopy revealed that plasma fibrin clots from PE subjects exhibited lower fiber density compared with those from DVT subjects. These data suggest that clot structure and functional properties differ between DVT and PE subjects and provide insights into mechanisms that may regulate embolization.

Entities:  

Keywords:  deep vein thrombosis; fibrin; lysis; pulmonary embolism

Mesh:

Substances:

Year:  2014        PMID: 24414255      PMCID: PMC3949054          DOI: 10.1152/ajplung.00265.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  25 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.

Authors:  J P Collet; Y Allali; C Lesty; M L Tanguy; J Silvain; A Ankri; B Blanchet; R Dumaine; J Gianetti; L Payot; J W Weisel; G Montalescot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-17       Impact factor: 8.311

3.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

4.  Isolated familial plasminogen deficiency may not be a risk factor for thrombosis.

Authors:  R C Tait; I D Walker; J A Conkie; S I Islam; F McCall
Journal:  Thromb Haemost       Date:  1996-12       Impact factor: 5.249

5.  Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis.

Authors:  K M Moser; P F Fedullo; J K LitteJohn; R Crawford
Journal:  JAMA       Date:  1994-01-19       Impact factor: 56.272

6.  Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.

Authors:  E Suenson; L C Petersen
Journal:  Biochim Biophys Acta       Date:  1986-04-22

7.  Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report.

Authors:  T Yamaki; M Nozaki; H Sakurai; M Takeuchi; K Soejima; T Kono
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-10-14       Impact factor: 7.069

8.  Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots.

Authors:  Michael Neyman; Jamie Gewirtz; Mortimer Poncz
Journal:  Blood       Date:  2008-06-16       Impact factor: 22.113

9.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Authors:  Kellie R Machlus; Jessica C Cardenas; Frank C Church; Alisa S Wolberg
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

10.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

View more
  13 in total

1.  Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.

Authors:  B A Herbig; S L Diamond
Journal:  J Thromb Haemost       Date:  2015-07-28       Impact factor: 5.824

Review 2.  Fibrinogen, red blood cells, and factor XIII in venous thrombosis.

Authors:  B L Walton; J R Byrnes; A S Wolberg
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 3.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 4.  Fibrin mechanical properties and their structural origins.

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Matrix Biol       Date:  2016-08-20       Impact factor: 11.583

5.  Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.

Authors:  Sravya Kattula; Yaqiu Sang; Gustaaf de Ridder; Anna C Silver; Emma G Bouck; Brian C Cooley; Alisa S Wolberg
Journal:  J Thromb Haemost       Date:  2021-09-06       Impact factor: 5.824

6.  A Fluid-Structure Interaction Analysis of Blood Clot Motion in a Branch of Pulmonary Arteries.

Authors:  Fateme Mirakhorli; Bahman Vahidi; Marzieh Pazouki; Pouria Talebi Barmi
Journal:  Cardiovasc Eng Technol       Date:  2022-07-05       Impact factor: 2.495

Review 7.  Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.

Authors:  Anetta Undas
Journal:  Biomed Res Int       Date:  2017-06-27       Impact factor: 3.411

8.  Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism.

Authors:  Robert W Kupis; Sarah Goldman-Mazur; Maciej Polak; Michał Ząbczyk; Anetta Undas
Journal:  Sci Rep       Date:  2019-01-11       Impact factor: 4.379

9.  Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots.

Authors:  Stella Salta; Loula Papageorgiou; Annette K Larsen; Patrick Van Dreden; Claire Soulier; Dennis V Cokkinos; Ismail Elalamy; Grigoris T Gerotziafas
Journal:  Res Pract Thromb Haemost       Date:  2018-07-17

10.  Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.

Authors:  Cédric Duval; Adomas Baranauskas; Tímea Feller; Majid Ali; Lih T Cheah; Nadira Y Yuldasheva; Stephen R Baker; Helen R McPherson; Zaher Raslan; Marc A Bailey; Richard M Cubbon; Simon D Connell; Ramzi A Ajjan; Helen Philippou; Khalid M Naseem; Victoria C Ridger; Robert A S Ariëns
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.